Cargando…
Ozurdex completely located inside a crystallized lens - Results of 14 months
PURPOSE: To report the therapeutic efficacy and results of an accidentally injected intralenticular sustained-release dexamethasone implant (Ozurdex) in a patient with macular edema secondary to central retinal vein occlusion at 14 months after injection. OBSERVATIONS: We present a 70-year-old femal...
Autores principales: | Baskan, Burhan, Cıcek, Ayşe, Gulhan, Ahmet, Gundogan, Medine, Goktas, Sertan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5757461/ https://www.ncbi.nlm.nih.gov/pubmed/29503921 http://dx.doi.org/10.1016/j.ajoc.2016.08.001 |
Ejemplares similares
-
Change in retinal vessel diameter and choroidal thickness in patients with severe COVID-19: Change In Retinal Parameters In Patients With Severe COVID-19
por: Gündoğan, Medine, et al.
Publicado: (2022) -
Intralenticular Ozurdex injection in an eye with thicker lens and the therapeutic effect maintained for 15 months
por: Li, Mu, et al.
Publicado: (2022) -
Wandering Ozurdex(®) implant
por: Bansal, Reema, et al.
Publicado: (2011) -
Misdirected ozurdex implant
por: Bhayana, Amber Amar, et al.
Publicado: (2021) -
Immortal Ozurdex: A 10-month follow-up of an intralenticular implant
por: Poornachandra, B, et al.
Publicado: (2017)